AI-generated summary
In a secondary analysis of a randomized trial, the authors report that repeated low-level red-light therapy in myopic children was associated with sustained choroidal thickening over one year, while single-vision spectacles were associated with thinning. They state that choroidal thickness changes at 3 months alone had reasonable accuracy for predicting 12-month myopia control. The analysis covered only two of five trial sites.
- Participants
- 120
- Who or what was studied
- Myopic children aged 8-13 years from 2 of 5 sites in a multicenter randomized controlled trial (60 receiving repeated low-level red-light therapy, 60 receiving single-vision spectacles)
- Wavelengths
- 650 nm
- Limits stated in the abstract
- This is a secondary analysis limited to 2 of 5 trial sites, and the abstract reports predictive accuracy only as areas under the curve of 0.710-0.786.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.